D. E. Shaw & Co »

Phathom Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 129k 9.13
2023-09-30 $1.4M 131k 10.37
2023-06-30 $1.6M 114k 14.32
2022-09-30 $160k 15k 11.05
2022-06-30 $525k 62k 8.43
2019-12-31 $234k 7.5k 31.08

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management
Checkpoint Capital

View all funds holding Phathom Pharmaceuticals